ClinicalTrials.Veeva

Menu

The Role of Convex Skin Barrier in Prevention of Peristomy Skin Complication-Randomized Controlled Trial

Chang Gung Medical Foundation logo

Chang Gung Medical Foundation

Status

Unknown

Conditions

Stoma Colostomy
Stoma Ileostomy

Treatments

Device: convex skin barrier

Study type

Interventional

Funder types

Other

Identifiers

NCT04202666
201901217A3C601

Details and patient eligibility

About

The incidence of peristomy skin complication ranges from 15% to 65%. It is a serious issue and problem for patients care.The type of skin barrier is associated with peristomy skin complication. How to choose suitable skin barrier is important.

Enrollment

300 estimated patients

Sex

All

Ages

20+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age>20
  • Receive colostomy or ileostomy
  • Agree to join the trial and sign the informed consent form

Exclusion criteria

  • Liver cirrhosis
  • Renal insufficiency
  • Severe malnutrition
  • Unstable vital sign
  • Not suitable after evaluation by Principal Investigator

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

300 participants in 2 patient groups

not convex skin barrier
No Intervention group
Description:
no intervention
convex skin barrier
Experimental group
Description:
intervention
Treatment:
Device: convex skin barrier

Trial contacts and locations

1

Loading...

Central trial contact

Wan Hsiang Hu

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems